Overview

Biosurgery Market Introduction:

Biosurgery Market is poised to value over USD 16.7 billion by 2028 end at a CAGR of over 5.5% during the forecast period 2021 to 2028. 

The growth of the geriatric population, coupled with the rise in the sheer number of sports-related injuries and surgeries, the need for adequate patient blood loss management, the increase in the clearance of biosurgery products by regulatory authorities are all factors that have played a role in the potential growth of the market. The market has much economic scope as new products and applications have been introduced. These biosurgery products are found in numerous applications ranging from gynecological surgery, orthopedic surgery, general surgery, cardiovascular surgery, neurological surgery, urological surgery, thoracic surgery and reconstructive surgery. 

Based on the segmentation, the market involves products such as surgical sealants and adhesives, soft tissue attachments, staple line reinforcement agents, bone graft substitutes, and hemostatic agents and adhesion barriers. The growing demand for hydrogel-based polymeric sealants has also been instrumental in the meteoric augmentation of the biosurgery market.

The Asia Pacific market region has been anticipated to register a high CAGR value over the forecast time frame. The APAC market is growing rapidly particularly in terms of biosurgery products. It's important to note that the ever-expanding healthcare expenditure, rising need for managing blood loss effectively and the growing number of surgical procedures are factors which have enhanced the market growth in the region. Large networks of key market players as well as the presence of native players and the growing prevalence of biosurgery products, are aspects which have been instrumental to the potential of the market. Therefore, the Asia Pacific region holds a substantial global biosurgery market share.

Major players included in the Biosurgery Market:
• Johnson & Johnson
• Baxter International Inc.
• Medtronic Plc
• Becton, Dickinson & Co.
• Tissue Regenix Group Plc  
• Stryker Corp.
• Integra Lifesciences Holdings Corp. 
• CSL Ltd.
• Hemostasis LLC.
• Pfizer Inc.
• Cyrolife Inc. 
• Zimmer Biomet
• Kuros Biosciences AG
• Orthofix Medical Inc.
• Smiths & Nephew Plc.
• Tissue Regenix Group Plc 
• Betatech Medical 
• Meril Lifesciences Pvt. Ltd.
• RTI Surgicals 
• Samyang Holdings Corp. 
(Note: The list of the major players will be updated with the latest market scenario and trends)

Biosurgery Market Segmentation:

By Product Type
• Bone Graft Substitutes
  o Demineralized bone matrix
  o Synthetic Bone Grafts
  o Bone Morphogenetic Proteins
  o Other Bone-Graft Substitutes
• Soft-tissue attachments
  o Synthetic meshes
  o Biological meshes
    • Allografts
    • Xenografts
• Hemostatic agents
  o Thrombin-based hemostatic agents
  o Oxidized regenerated cellulose-based hemostatic agents
  o Combination hemostatic agents
• Surgical sealants and adhesives
  o Natural/Biological Sealants and Adhesives
    • Natural/Biological Sealants and Adhesives, By Type
      • Fibrin Sealants
      • Collagen-Based Sealants
      • Gelatin-Based Sealants
      • Albumin-Based Sealants
      • Other Natural/Biological Sealants
    • Natural/Biological Sealants and Adhesives, By Origin
      • Human Blood-Based Sealants and Adhesives
      • Animal-Based Sealants and Adhesives
  o Synthetic and Semi-Synthetic Sealants and Adhesives
    • Peg Hydrogels
    • Cyanoacrylate-Based Sealants and Adhesives
    • Urethane-Based Sealants and Adhesives
    • Other Synthetic and Semi-Synthetic Sealants and Adhesives
• Adhesion Barriers
  o Synthetic Adhesion Barriers
    • Hyaluronic Acid-Based Adhesion Barriers
    • Regenerated Cellulose-Based Adhesion Barriers
    • Peg-Based Adhesion Barriers
    • Other Synthetic Adhesion Barriers
  o Natural Adhesion Barriers
    • Collagen & Protein Adhesion Barriers
    • Fibrin-Based Adhesion Barriers
• Staple-Line Reinforcement Agents

By Application:  
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Urological Surgery
• Thoracic Surgery
• Others

By End User
• Hospitals
• Clinics
• Others

By Region: 

•  North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

FutureWise Key Takeaways: 

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the global bio surgery market by product type, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and the Middle East & Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics